NCT03399474View on ClinicalTrials.gov

Analgesic Efficacy of Two Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

July 30, 2020

Study Completion Date

August 30, 2020

Conditions
Limb Deformity
Interventions
DRUG

Lidocaine Hydrochloride 2%

Lidocaine Hydrochloride 2%

DRUG

Dexmedetomidine 0.5 ug/kg

pecedex

DRUG

Dexmedetomidine Injection 0.25 ug/kg

pecedex

Trial Locations (1)

71515

Ghada M Ab Elfadl, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03399474 - Analgesic Efficacy of Two Doses of Dexmedetomidine as Adjuncts to Lidocaine for Intravenous Regional Anesthesia | Biotech Hunter | Biotech Hunter